News

In this month’s Employee Spotlight, we’re excited to feature Thomas Kenney, MetrumRG’s  Administrative Assistant and member of the Talent & Culture Team. Thomas's role is integral to the smooth functioning of our office. He is responsible for various clerical and organizational tasks, assists with monthly expense reporting, and ensures that our office is always stocked with a variety of coffee—a task that he humorously notes might be the most important of all.

What do you like most about working at MetrumRG?

"It's hard to choose what I like most about working here. Before joining the civilized working world, the majority of my experience was in fast-paced and high-stress emergency service jobs. I used to work in dimly lit, windowless rooms from 6:00 PM to 6:00 AM with a group of over-caffeinated EMTs, police officers, firefighters, and dispatchers.

I am excited to share that one of our recent papers written in collaboration with EMD Serono, Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab, has been recognized as one of the most cited in its publication last year. Reflecting on this achievement, I wanted to provide some insights into why I believe this paper resonated so strongly with the pharmacometrics community and became such a valuable resource.

We're excited to shine the spotlight on Kiersten Utsey, a valued member of our team here at MetrumRG. Her primary focus involves utilizing mechanistic modeling and simulation to support decision-making processes throughout various stages of drug development. This entails synthesizing data from diverse sources, including in vitro studies, animal models, and clinical trials, to construct models that describe both the mechanism of action of drugs and the underlying physiology of diseases. Kiersten initially joined MetrumRG as a Quantitative Systems Pharmacology Intern while working on her Ph.D. in Mathematics at the University of Utah. After graduating from the U, Kiersten transitioned into a role as a research associate at MetrumRG. Quickly advancing, she became a research scientist in our Translational Science and Pharmacology (TSP) group. 

Twenty years ago, the Metrum Research Group journey began. Marc Gastonguay and Jeff Hane founded the company in 2004 with a mission to improve health and defeat disease.

I joined Metrum Research Group in the Fall of 2022 as a research scientist in PKPD, driven by a passion for modeling and simulation analyses of clinical trial data. My journey into this field was profoundly shaped by my experiences during a post-doc at a nonprofit organization, where I had the chance to collaborate closely with patient advocacy groups in the rare disease community. Their unwavering determination and resilience have inspired me to continue my work towards finding cures and creating innovative drug development solutions. In honor of Rare Disease Day, I am grateful to have the opportunity to share my journey of fruitful collaboration that has shaped my perspective.

Eric Anderson has been an invaluable member of the MetrumRG team since 2017. Over the years, has contributed a practical and dedicated approach to skillfully navigating the complexities of data.

Eric began his career in the insurance industry as an actuarial analyst. His experience in analyzing insurance data and modeling risk put him in a position to smoothly transition into the field of model-informed drug development at MetrumRG. In his current role, Eric assembles clinical trial data into model-ready datasets, creates visualizations (including interactive dashboards) to help describe data, and develops tools to help facilitate these and other modeling project tasks.

In the spirit of giving back, the MetrumRG team participated in an Annual Toy Drive benefiting Connecticut Children’s.  Over the years,  our team has made the holidays a little brighter by donating hundreds of toys to children throughout Connecticut, Eastern New York, and Western Massachusetts.

In this edition of our Employee Spotlight, we are delighted to introduce you to Danielle Dunn, one of the original team members at MetrumRG. Danielle's journey with the company has been one of unwavering dedication and commitment. For nearly two decades, she has been an integral part of our growth and success.

Metrum Research Group proudly welcomes Dr. Daniel Kirouac, Ph.D., as the Vice President of Translational and Systems Pharmacology (TSP). Dr. Kirouac brings over a decade of experience spanning academia, small biotech, big pharma, and consulting roles. His expertise in computational modeling and translational science will play a significant role in advancing drug development strategies at MetrumRG.

Metrum Research Group has proudly earned a place on the Marcum Tech Top 40 list for the 13th year. At MetrumRG, we are passionate about our mission to defeat disease. We provide innovative solutions at the intersection of data, science, and technology to generate key insights that impact biomedical decision-making.